A Phase II Study Of SB939 In Patients With Recurrent Or Metastatic Castration Resistant Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 05 Jul 2018
At a glance
- Drugs Pracinostat (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 19 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Feb 2014 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.